Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2005 Jul;242(1):1-6; discussion 7-9.
doi: 10.1097/01.sla.0000167759.15670.14.

A randomized trial comparing axillary dissection to no axillary dissection in older patients with T1N0 breast cancer: results after 5 years of follow-up

Gabriele Martelli  1 , Patrizia Boracchi, Michaela De Palo, Silvana Pilotti, Saro Oriana, Roberto Zucali, Maria Grazia Daidone, Giuseppe De Palo
Affiliations
Clinical Trial

A randomized trial comparing axillary dissection to no axillary dissection in older patients with T1N0 breast cancer: results after 5 years of follow-up

Gabriele Martelli et al. Ann Surg. 2005 Jul.

Abstract

Summary background data: Axillary dissection, an invasive procedure that may adversely affect quality of life, used to obtain prognostic information in breast cancer, is being supplanted by sentinel node biopsy. In older women with early breast cancer and no palpable axillary nodes, it may be safe to give no axillary treatment. We addressed this issue in a randomized trial comparing axillary dissection with no axillary dissection in older patients with T1N0 breast cancer.

Methods: From 1996 to 2000, 219 women, 65 to 80 years of age, with early breast cancer and clinically negative axillary nodes were randomized to conservative breast surgery with or without axillary dissection. Tamoxifen was prescribed to all patients for 5 years. The primary endpoints were axillary events in the no axillary dissection arm, comparison of overall mortality (by log rank test), breast cancer mortality, and breast events (by Gray test).

Results: Considering a follow-up of 60 months, there were no significant differences in overall or breast cancer mortality, or crude cumulative incidence of breast events, between the 2 groups. Only 2 patients in the no axillary dissection arm (8 and 40 months after surgery) developed overt axillary involvement during follow-up.

Conclusions: Older patients with T1N0 breast cancer can be treated by conservative breast surgery and no axillary dissection without adversely affecting breast cancer mortality or overall survival. The very low cumulative incidence of axillary events suggests that even sentinel node biopsy is unnecessary in these patients. Axillary dissection should be reserved for the small proportion of patients who later develop overt axillary disease.

PubMed Disclaimer

Figures

None
FIGURE 1. Crude cumulative incidence curves of breast events in two treatment groups.
None
FIGURE 2. Crude cumulative incidence curves of breast cancer mortality in the two treatment groups.
None
FIGURE 3. Overall survival curves in the two treatment groups.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Halsted WS. The results of radical operations for the cure of cancer of the breast. Ann Surg. 1907;46:1–5. - PMC - PubMed
    1. Fisher B, Redmond C, Fisher ER, et al. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med. 1985;312:674–681. - PubMed
    1. Gervasoni JE Jr, Taneja C, Chung MA, et al. Axillary dissection in the context of the biology of lymph node metastases. Am J Surg. 2000;180:278–283. - PubMed
    1. Veronesi U, Paganelli G, Viale G, et al. Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series. J Natl Cancer Inst. 1999;91:368–373. - PubMed
    1. Tabar L, Smith RA, Vitak B, et al. Mammographic screening: a key factor in the control of breast cancer. Cancer J. 2003;9:15–27. - PubMed

Publication types

MeSH terms

LinkOut - more resources